BRIEF published on 01/30/2026 at 18:05, 7 months 11 days ago EUROLAND CORPORATE: Shares and voting rights as of January 30, 2026 Voting Rights Actions Investment Euronext Growth EuroLand Corporate
BRIEF published on 01/30/2026 at 18:05, 7 months 11 days ago EUROLAND CORPORATE : Actions et droits de vote au 30 janvier 2026 Investissement Droits De Vote Actions Euronext Growth EuroLand Corporate
PRESS RELEASE published on 01/30/2026 at 18:00, 7 months 11 days ago Information relative aux actions et droits de vote EUROLAND CORPORATE, société cotée sur Euronext Growth Paris, communique le nombre d'actions et de droits de vote en date du 30 janvier 2026 Euronext Growth Paris Droits De Vote Actions Communication EuroLand Corporate
BRIEF published on 01/29/2026 at 18:05, 7 months 12 days ago EuroLand Corporate Unveils its 2026 Financial Calendar Financial Calendar Annual Report General Assembly EuroLand Corporate Communication Date
BRIEF published on 01/29/2026 at 18:05, 7 months 12 days ago EuroLand Corporate Dévoile son Calendrier Financier 2026 Calendrier Financier Assemblée Générale Rapport Annuel EuroLand Corporate Communication Date
PRESS RELEASE published on 01/29/2026 at 18:00, 7 months 12 days ago EuroLand Corporate Calendrier Financier 2026 EuroLand Corporate annonce son calendrier de communication financière pour 2026 incluant le rapport financier annuel, l'assemblée générale et le rapport financier semestriel Calendrier EuroLand Corporate LinkedIn Exercice 2026 Communication Financière
BRIEF published on 10/31/2025 at 17:50, 10 months 10 days ago EUROLAND CORPORATE: Information on Shares and Voting Rights Voting Rights Actions Euronext Growth 2025 EuroLand Corporate
BRIEF published on 10/31/2025 at 17:50, 10 months 10 days ago EUROLAND CORPORATE : Informations sur les Actions et Droits de Vote Droits De Vote Actions Euronext Growth 2025 EuroLand Corporate
PRESS RELEASE published on 10/31/2025 at 17:45, 10 months 10 days ago Information relative aux actions et droits de vote EuroLand Corporate communique les chiffres clés : 3 173 068 actions, 5 421 552 droits de vote théoriques, 5 310 461 droits de vote exerçables. Société cotée sur Euronext Growth Paris Euronext Growth Paris Communication Financière Droits De Vote Chiffres Clés EuroLand Corporate
BRIEF published on 10/01/2025 at 08:35, 11 months 10 days ago État des actions et des droits de vote d'EuroLand Corporate Droits De Vote Actions Paris Euronext Growth EuroLand Corporate
Published on 09/11/2026 at 04:00, 5 hours 51 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 26 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 31 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 51 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 31 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 46 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 51 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 2 hours 51 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 51 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 51 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 21 minutes ago Availability of the 2026 Interim Financial Report
